Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CBWD3 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
mRNA | PABPC3 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | BAX | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
mRNA | SLC25A44 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
mRNA | MRPS14 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
mRNA | EMID1 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
mRNA | ZSCAN2 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
mRNA | ACSM1 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
mRNA | GPR89B | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
mRNA | DARS2 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |